Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E F de Zoeten"'
Autor:
Claire E. Gustafson, Cara C. Wilson, E F de Zoeten, Paul Jedlicka, D Higbee, A R Yeckes, Edward N. Janoff
Publikováno v:
Mucosal immunology
The absence of immunoglobulin A (IgA) in the intestinal tract renders young infants highly susceptible to enteric infections. However, mediators of initial IgA induction in this population are undefined. We determined the temporal acquisition of plas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c0ad801945da298ee6a6a872d3a921
https://doi.org/10.1038/mi.2013.64
https://doi.org/10.1038/mi.2013.64
Autor:
Carol M. Aherne, E F de Zoeten, Paul Jedlicka, Colm B. Collins, Kayla Pound, Alyson Yeckes, Holger K. Eltzschig
Publikováno v:
Mucosal immunology
Inflammatory bowel disease (IBD) is a chronic inflammatory condition thought to reflect a failure of the enteral immune system to adequately regulate itself. Inflammatory stress drives upregulation of heat-shock proteins (HSPs), including the pro-inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e315949d3c8340e15a370cda8b18f8b4
https://doi.org/10.1038/mi.2012.134
https://doi.org/10.1038/mi.2012.134
Autor:
Sean P. Colgan, Louise E. Glover, C. R. Rapp, Carol M. Aherne, Eóin N. McNamee, Holger K. Eltzschig, Amanda J. Bayless, A Fletcher, Joanne C. Masterson, Colm B. Collins, Paul Jedlicka, Christopher M. Evans, Bejan Saeedi, E F de Zoeten, Glenn T. Furuta, Vivienne Curtis, L. Perrenoud
Central to inflammatory bowel disease (IBD) pathogenesis is loss of mucosal barrier function. Emerging evidence implicates extracellular adenosine signaling in attenuating mucosal inflammation. We hypothesized that adenosine-mediated protection from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda74da8db7439c2b6da141b9d87cc6c
http://mural.maynoothuniversity.ie/12484/
http://mural.maynoothuniversity.ie/12484/
Publikováno v:
Gene Therapy. 9:1163-1172
Most neoplasms do not induce antitumor immune responses that can control tumor growth. Tumor associated antigens (TAAs) are insufficiently immunogenic. A vaccine that augments the immunogenic properties of TAAs could be of importance in the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e033441bb28dd6ef4493968e8a1f9c1b
https://doi.org/10.1038/sj.gt.3301765
https://doi.org/10.1038/sj.gt.3301765
Autor:
Sean P. Colgan, Christopher M. Evans, Holger K. Eltzschig, E F de Zoeten, C. R. Rapp, Bejan Saeedi, Leanne Glover, Colm B. Collins, Joanne C. Masterson, Angharad Fletcher, L. Perrenoud, Glenn T. Furuta, Paul Jedlicka, Carol M. Aherne, Eóin N. McNamee, Vivienne Curtis, Amanda J. Bayless
Publikováno v:
Mucosal Immunology. 8:699
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d6d56251bdb54eace668f3b23604b75
https://doi.org/10.1038/mi.2015.41
https://doi.org/10.1038/mi.2015.41
Publikováno v:
Cancer gene therapy. 5(2)
Altered genes in tumor cells specify tumor-associated antigens. Because genetic instability is a characteristic of the malignant cell phenotype, a large number of different, altered genes may be present in a population of neoplastic cells, specifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b35aff81dd5ae7b4cc35b9df7c491de7
https://pubmed.ncbi.nlm.nih.gov/9570302
https://pubmed.ncbi.nlm.nih.gov/9570302
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 160(6)
Tumor-associated Ags (TAA) that characterize a population of malignant cells are recognized by CTLs in the context of determinants specified by the MHC class I locus. Nevertheless, most progressively growing neoplasms do not induce antitumor immune r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bee36a9ea879f19b322781156ed339ce
https://pubmed.ncbi.nlm.nih.gov/9510195
https://pubmed.ncbi.nlm.nih.gov/9510195